Ares Financial Consulting’s Vaxcyte PCVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-32
Closed -$1.86K – 1117
2026
Q2
$1.86K Buy
+32
New +$1.74K ﹤0.01% 904

Other funds holding PCVX

Ares Financial Consulting's PCVX Position: Q3 2026 in Review

Ares Financial Consulting sold out of Vaxcyte (PCVX) in Q3 2026, closing a stake of 32 shares — an estimated $1.86K sold.

Ares Financial Consulting first reported a position in PCVX in Q2 2026 and held it in 1 quarter. The position peaked at $1.86K in Q2 2026. 272 funds tracked by Wall St. Rank hold PCVX as of Q3 2026.

  • Ares Financial Consulting reported no remaining Vaxcyte position as of Q3 2026 after selling out during the quarter.
  • Ares Financial Consulting sold 32 Vaxcyte shares in Q3 2026, an estimated $1.86K.
  • Ares Financial Consulting first reported a position in Vaxcyte in Q2 2026 and held it in 1 quarter.
  • Ares Financial Consulting's Vaxcyte position peaked at $1.86K in Q2 2026.
  • 272 funds tracked by Wall St. Rank held Vaxcyte as of Q3 2026.

Based on Ares Financial Consulting's 13F filing for Q3 2026, filed 19 Oct 2026.